Clinical Trial Update: A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6) [Phase 3]

View source ↗

Summary

Phase 3 ONWARDS 6 study comparing once-weekly insulin icodec with daily insulin degludec, both used with mealtime insulin, in people with Type 1 diabetes; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin Icodec (insulin icodec)
• insulin degludec (insulin degludec)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2025-06-12